Welcome back to our blog series on National Member News!

 

We are excited about getting our National Member news out to the world! We want more people to find out what it is happening in each country and each member organisation! We caught up with Elina Eklund from Lupus Finland, who talked to us about the brilliant work the organisation is doing, the needs of lupus patients in Finland,  COVID19 and a lot more!

 

How do you keep in touch with or have contact with your members?

 

We have always had a lot of online connections with our members.  Our group, Lupus Finland, first started by getting people involved online and we have mainly been an online working group due to the distances in the country. Finland is a very long country and since lupus is a rare disease, we have members from all around Finland.

 

We do have some local meetings like lupus coffee breaks. We encourage people to meet locally, where that is possible, but whether that is possible or how often it’s possible does depend on the city or location. The local gatherings started on World Lupus Day some years ago. In some cities these gatherings continued after World Lupus Day as coffee breaks.

 

For our online work we have groups on facebook, we’ve found that to be a good forum for discussion groups. (We are not as active on all social media channels like twitter or Instagram, the) facebook page of our group is our most active social media channel. We also do try to have 1-2 events a year, events where we can have some lectures, work and a bit of leisure time together with other members of the group.

 

Did you have any special meetings or webinars during the past year (World Lupus Day, Rare Disease Day, Annual General Meeting etc)?

 

Yes! As it happens our group was founded 20 years ago, so this is an anniversary year for us. On World Lupus Day we announced the group’s new name: the name has now officially changed from SLE Finland to Lupus Finland. All group members received a mask with a butterfly on it, which is our logo, as a gift to celebrate the 20 year anniversary of the group!

 

 

 

 

 

 

 

 

 

 

On World Lupus Day we also had a lecture on SLE by a rheumatologist specialising in lupus. the theme this year for our group was “Making Lupus Visible”. We also had a facebook campaign for World Lupus Day, for which we followed the Lupus Europe theme to celebrate the day.

 

Has it been difficult to keep connected with your members during the Covid19 pandemic?

 

As we always been a mainly online group, it wasn’t difficult for us to keep connected with our members during the pandemic. Due to the long distances between the cities in Finland, most meetings and lectures we’ve had as a group have always been online as well.

 

Have there been any circumstances during the pandemic that changed the way of living with lupus?

 

Absolutely. There is an uncertainty because of the pandemic that is around all of us, but especially those of us who are in at higher risk groups in case of covid.

 

For lupus patients in Finland, our daily lives have changed during the pandemic. We are always aware of covid and we’re always being cautious of the possibilities and risks of the virus. There may be an increased need for social distancing in lupus patients due to the fact that many of us are at higher risk groups for complications from covid infections.  So of course, this uncertainty affects us.  

 

Last year most of us lived with strict rules and lockdown. In Finland there are still restrictions about gatherings and some other things and it’s an ongoing process. Events still get cancelled et cetera; covid has affected everyone in so many ways, let alone those of us with a disease that makes us more vulnerable to it.

 

On top of everything else there are also a lot of questions about the covid19 vaccines. There are questions about the safety of the vaccines and a lot of unknowns for people and there are questions about the effectiveness of the vaccines too. It’s a lot; there are many things one has to consider.

 

In all this there is a need for valid, good information around the pandemic. This is important for everyone, but even more so for lupus patients.

 

Has Digital Health improved or changed in your country?

 

Yes! Many improved or new digital possibilities are available now or have been developed specifically as a result of the pandemic. Online services for different situations and instances are now more widely provided.

 

A person might have a consultation with their doctor online now, via video call for example. Also one can connect with a healthcare professional digitally now; there are some platforms where one can, for example, message their doctor, nurse or other healthcare provider kind of like e-consults. Some of these services were developed due to the pandemic or taken up more widely and offered more widely because of the pandemic. There are pros and cons for this also.

 

People who have access to electronic devices (i.e. computers or smartphones) and the skills to use them, can benefit from these new digital health possibilities. Those who lack the knowledge, aren’t able to use IT or who may not have the access to electronic devices are in a different position.

 

What would you most need as support in your country for lupus?

 

There is a lot being done already in Finland for Lupus. In general, information is really welcome and now we are excited that information is something that we can get from Lupus Europe!

 

Education around lupus, access to different kinds of courses; they are very welcome too. Anything that can be a tool for our group’s Board, something that we could use to improve and develop the work of our National group to meet the needs of our members would be very welcome.  

 

In terms of information, so many different levels and types of information are needed. Information about lupus in general is vital too, increasing people’s awareness and knowledge is essential. Information about what lupus is, what type of lupus a person may have and what that might mean. This is important for healthcare professionals and for patients too. When you think about it, lupus a rare disease and any rare disease brings challenges of not being understood or not being taken into consideration.

 

If lupus was more common, it might be that it would be better and more widely understood and more accepted somehow even. It’s difficult for the general public to be aware of lupus because it’s a rare disease, but also because it changes all the time and we all have different kinds of lupus and different symptoms even within the same type of lupus. Increasing public awareness of lupus is essential. 

 

Is there anything you think Lupus Europe could help your organisation with?  

 

One of the important aims for our group is increasing public awareness of lupus, awareness among healthcare professionals of lupus and awareness and knowledge of lupus among people with lupus too.

 

We would want to continue getting from Lupus Europe tools for improving our work and tools that may help us develop our work, such as courses or information. This, of course, is also about us taking on the materials and the things Lupus Europe does provide us! It’s not a one-way street, it’s also about us taking on and using the resources there are already available.

 

We also have to remember that we are a small language group and not all of us are able to receive the information in English.

 

For example, the materials for World Lupus Day and other materials or resources; we first need to translate the materials into Finnish before we can share them. One can’t benefit from courses or information if there is a language barrier. This is an issue with small language groups I imagine- only about 5 million people speak Finnish.

 

Is there any topic/theme/area that you think Lupus Europe should focus on, on something where European collaboration would make sense?

 

Any and all collaboration and synergy are definitely good things. Increasing awareness of and knowledge about lupus are really needed. We’ve already covered how information is needed, but increasing awareness and knowledge would also be good all around. And of course this is already being provided and that’s good.

 

Are you aware of the Lupus Europe Member Capacity Building Program?

 

We have received information about it. It’s on our to do list. 

 

Could you tell us a bit about a dream you have as a group?

 

I keep repeating myself, but our dream would be that everyone knows what lupus is.  Of course, there are different kinds of dreams, and we have many as a group!  Another dream of ours would be that people with lupus can do better and have a very good quality of life.  We want our group to be beneficial to our members and well developed, so another dream of ours is that the information about our group and about lupus can be easily accessible for people.

 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

💜 We've taken part in the EULAR PARE Conference 2026 in Brussels! And what an interesting opportunity to discuss the future of AI in healthcare!

🌍 Bringing together more than 100 delegates and speakers from across Europe and beyond, the conference explored some of the most important questions surrounding artificial intelligence in rheumatology and patient advocacy.

From the opportunities and risks of AI to health inequalities, accessibility and European health policy, the discussions highlighted why patient perspectives must be part of the conversation.

🤩 We were particularly proud to see Jeanette Andersen, Chair of the Lupus Europe Board, sharing our experience with #LupusGPT in her presentation, “AI as a Partner in Care: Empowering the RMD Community with Information”.

💡 Jeanette explained how #LupusGPT was developed with patients and clinicians to offer free, multilingual access to reliable lupus information based on validated sources.

She also introduced #EasyLupus, which provides the same trusted information in simpler language, highlighting why accessibility must be considered when developing AI tools.

But one of the most important messages from her presentation went beyond technology.

💜 Patient organisations have much more to contribute to AI than simply using tools developed by others.

As Jeanette highlighted, patient organisations bring lived experience, knowledge of unmet needs, trusted information and an understanding of the barriers people face when accessing health information.

Technology alone cannot tell us what patients really need or what makes a tool genuinely useful.

Patients and patient organisations should not simply be users of AI. They should help shape its development.

👏 A big thank you to EULAR PARE for bringing together so many different perspectives and creating space for meaningful discussions about the future of healthcare and patient involvement!
...

💜 Weve taken part

🦋 One of the greatest strengths of patient organisations is the support, understanding and sense of community they offer to people living with lupus. 💜

🇧🇬 A great example comes from Организация на пациентите с ревматологични заболявания, who shared their psychological support initiative at the #LupusConvention!

💜 Launched in December 2025, this pilot project provides a safe and supportive space where participants can share their experiences and discuss the challenges of living with lupus, from fatigue and anxiety to relationships and everyday life.

👥 Led by a clinical psychologist, the group currently brings together six women. The project is expected to run until December 2026, while the organisation explores funding opportunities to continue and expand the initiative.

Thank you to our Bulgarian colleagues for sharing their experience, and congratulations on the amazing job you are doing! ❤️

🌍 This is just one example of the valuable work patient organisations are doing across Europe, often responding to needs that go beyond medical care. We'll share more in the coming days!

💜 Are you living with lupus? You don't have to navigate everything alone! Your national lupus organisation may offer information, support, activities and opportunities to connect with others who understand your experiences.

🔗 Find your national lupus organisation and get in touch:
lupus-europe.org/lupus-members/
...

Image attachment
Image attachment

💜 Young people living with lupus are not only the future of patient advocacy. Their voices matter today!

On 23 and 24 October, LUPUS EUROPE was delighted to be represented at the first 𝗘𝗣𝗙 𝗬𝗼𝘂𝘁𝗵 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟲 in Brussels by Ana Rita Vieira, from the LUPUS EUROPE Youth Group, and Lena Koskina, LUPUS EUROPE's Youth Group Coordinator.

🌍 Organised by European Patients' Forum and its EPF Youth Group, the Congress brought together young patient advocates from across Europe to explore the challenges facing young people living with chronic conditions, from economic uncertainty and climate change to the barriers they encounter when trying to influence healthcare decisions.

🌟 One particularly important question ran through the discussions: 𝗵𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗺𝗼𝘃𝗲 𝗯𝗲𝘆𝗼𝗻𝗱 𝘀𝗶𝗺𝗽𝗹𝘆 𝗴𝗶𝘃𝗶𝗻𝗴 𝘆𝗼𝘂𝗻𝗴 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮 𝘀𝗲𝗮𝘁 𝗮𝘁 𝘁𝗵𝗲 𝘁𝗮𝗯𝗹𝗲, 𝗮𝗻𝗱 𝗲𝗻𝘀𝘂𝗿𝗲 𝘁𝗵𝗲𝘆 𝗵𝗮𝘃𝗲 𝗮 𝗿𝗲𝗮𝗹 𝘀𝗮𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗯𝗲𝗶𝗻𝗴 𝗺𝗮𝗱𝗲❓

The conversations also highlighted something easily overlooked: 𝗺𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮𝗻 𝗶𝗻𝘃𝗶𝘁𝗮𝘁𝗶𝗼𝗻. Young people living with chronic conditions are often balancing their health with education, employment and financial pressures. Advocacy opportunities need to recognise those realities, and not be accessible only to those who can afford the time and resources to participate.

🦋 At LUPUS EUROPE, supporting the Youth Group means actively helping create those opportunities, connecting young advocates with others across Europe and ensuring their perspectives can meaningfully contribute to the work we do.

Young people living with lupus are already advocates, bringing their experiences, ideas and knowledge into conversations that matter.

💜 Thank you to European Patients' Forum and its EPF Youth Group for bringing everyone together, and to Rita and Lena for representing LUPUS EUROPE at this important Congress!
...

💜 Young people li

🔊 Hot off the press!

💜 Treatment adherence is important, complex and multifactorial.

But understanding the importance of treatment adherence is not the same as knowing how to support it in everyday clinical practice.

That’s why, in 2020, EULAR published its Points to Consider for the prevention, screening, assessment and management of nonadherence to treatment in people with rheumatic and musculoskeletal diseases.

But having recommendations is only the first step. How can we ensure they become part of everyday clinical practice?

🤩 An interesting new viewpoint published in EULAR Rheumatology Open, co-authored by Jeanette Andersen, Chair of the Lupus Europe Board, now explores the challenges of putting these recommendations into routine rheumatology care.

The article highlights that nonadherence is not simply a matter of individual patient behaviour. Concerns about treatment, practical difficulties, access to medication, socioeconomic circumstances and communication with healthcare professionals can all play a role.

The authors highlight five key priorities for putting adherence support into routine rheumatology practice:

🔹 Assessment: Identifying adherence behaviours and the barriers behind them.
🔹 Monitoring: Reassessing adherence over time, as it may change throughout the disease course.
🔹 Shared decision-making: Discussing patients’ preferences, expectations and concerns through non-judgemental communication.
🔹 Multidisciplinary care: Involving the wider healthcare team according to individual needs.
🔹 Training: Making adherence support part of rheumatology education and professional development.

💜 The challenge is not the lack of recommendations, but making adherence assessment and support a routine part of rheumatology care.

📖 Read the open-access viewpoint: doi.org/10.1016/j.ero.2026.100261
...

Image attachment
Image attachment
Image attachment
Image attachment
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send